CHEDIAK-HIGASHI SYNDROME
Clinical trials for CHEDIAK-HIGASHI SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CHEDIAK-HIGASHI SYNDROME trials appear
Sign up with your email to follow new studies for CHEDIAK-HIGASHI SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Milder stem cell transplant offers hope for kids with rare immune diseases
Disease control OngoingThis study tests a less intense stem cell transplant for children and young adults up to age 28 with various immune system disorders. The goal is to see if a milder pre-transplant treatment can help donor cells take hold with fewer serious side effects. The study tracks engraftme…
Matched conditions: CHEDIAK-HIGASHI SYNDROME
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 05:10 UTC
-
Stem cell transplant offers new hope for kids with rare immune diseases
Disease control OngoingThis study tests a donor stem cell transplant to treat severe immune system problems in 57 people. The goal is to help the body make healthy blood cells and fight infections. Patients must have a specific immune disorder and meet health criteria to join.
Matched conditions: CHEDIAK-HIGASHI SYNDROME
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 04:36 UTC